PL3773715T3 - Mirikizumab w leczeniu wrzodziejącego zapalenia jelita grubego - Google Patents
Mirikizumab w leczeniu wrzodziejącego zapalenia jelita grubegoInfo
- Publication number
- PL3773715T3 PL3773715T3 PL19722256.5T PL19722256T PL3773715T3 PL 3773715 T3 PL3773715 T3 PL 3773715T3 PL 19722256 T PL19722256 T PL 19722256T PL 3773715 T3 PL3773715 T3 PL 3773715T3
- Authority
- PL
- Poland
- Prior art keywords
- mirikizumab
- treatment
- ulcerative colitis
- ulcerative
- colitis
- Prior art date
Links
- 206010009900 Colitis ulcerative Diseases 0.000 title 1
- 201000006704 Ulcerative Colitis Diseases 0.000 title 1
- 229950009792 mirikizumab Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862650314P | 2018-03-30 | 2018-03-30 | |
| PCT/US2019/024633 WO2019191464A1 (en) | 2018-03-30 | 2019-03-28 | Methods of treating ulcerative colitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3773715T3 true PL3773715T3 (pl) | 2024-08-19 |
Family
ID=66429483
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL19722256.5T PL3773715T3 (pl) | 2018-03-30 | 2019-03-28 | Mirikizumab w leczeniu wrzodziejącego zapalenia jelita grubego |
Country Status (29)
| Country | Link |
|---|---|
| US (2) | US12152072B2 (pl) |
| EP (2) | EP3773715B1 (pl) |
| JP (4) | JP7119114B2 (pl) |
| KR (1) | KR102552693B1 (pl) |
| CN (1) | CN111936165A (pl) |
| AU (2) | AU2019243283C1 (pl) |
| BR (1) | BR112020018099A2 (pl) |
| CA (1) | CA3095297A1 (pl) |
| DK (1) | DK3773715T3 (pl) |
| EA (1) | EA202091989A1 (pl) |
| ES (1) | ES2983809T3 (pl) |
| FI (1) | FI3773715T3 (pl) |
| HR (1) | HRP20240904T1 (pl) |
| HU (1) | HUE067445T2 (pl) |
| IL (2) | IL277514B2 (pl) |
| LT (1) | LT3773715T (pl) |
| MA (1) | MA52216B1 (pl) |
| MD (1) | MD3773715T2 (pl) |
| MX (1) | MX2020010269A (pl) |
| MY (1) | MY202368A (pl) |
| PL (1) | PL3773715T3 (pl) |
| PT (1) | PT3773715T (pl) |
| RS (1) | RS65661B1 (pl) |
| SG (1) | SG11202009526RA (pl) |
| SI (1) | SI3773715T1 (pl) |
| TW (2) | TWI744617B (pl) |
| UA (1) | UA128578C2 (pl) |
| WO (1) | WO2019191464A1 (pl) |
| ZA (1) | ZA202005388B (pl) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20220012883A (ko) | 2019-05-23 | 2022-02-04 | 얀센 바이오테크 인코포레이티드 | Il-23 및 tnf 알파에 대한 항체의 병용요법으로 염증성 장질환을 치료하는 방법 |
| CN115427444A (zh) * | 2020-02-14 | 2022-12-02 | 詹森生物科技公司 | 用抗il12/il23抗体治疗溃疡性结肠炎的安全且有效的方法 |
| BR112022023489A2 (pt) | 2020-05-21 | 2023-03-14 | Janssen Biotech Inc | Método de tratamento de doença inflamatória intestinal com uma terapia de combinação de anticorpos para il-23 e tnf-alfa |
| WO2022085739A1 (ja) * | 2020-10-20 | 2022-04-28 | 協和化学工業株式会社 | 治験管理装置、治験管理方法、治験管理プログラム及び治験管理システム |
| EP4274849A1 (en) * | 2021-01-06 | 2023-11-15 | AbbVie Inc. | Methods of treating crohn's disease and ulcerative colitis |
| BR112023024064A2 (pt) * | 2021-05-20 | 2024-01-30 | Janssen Biotech Inc | Método de tratamento de doença inflamatória intestinal com uma terapia de combinação de anticorpos para il-23 e tnf-alfa |
| EP4347018A1 (en) * | 2021-05-28 | 2024-04-10 | Eli Lilly and Company | Anti-il-23p19 antibody regulation of genes involved in ulcerative colitis |
| EP4623001A1 (en) * | 2022-11-22 | 2025-10-01 | Janssen Biotech, Inc. | Method of treating ulcerative colitis with anti-il23 specific antibody |
| CN121079321A (zh) | 2023-03-10 | 2025-12-05 | 伊莱利利公司 | 治疗溃疡性结肠炎的方法 |
| WO2024255867A1 (zh) * | 2023-06-16 | 2024-12-19 | 信达生物制药(苏州)有限公司 | 重组抗白介素23p19亚基抗体在治疗炎症性肠病中的用途 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2410406T3 (es) * | 2005-06-30 | 2013-07-01 | Janssen Biotech, Inc. | Anticuerpos anti-IL-23, composiciones, procedimientos y usos |
| EP3219328B1 (en) | 2005-12-29 | 2020-06-17 | Janssen Biotech, Inc. | Human anti-il-23 antibodies, compositions, method and uses |
| ATE554791T1 (de) | 2007-02-23 | 2012-05-15 | Schering Corp | Gentechnisch hergestellte anti-il-23p19- antikörper |
| JP2012507723A (ja) * | 2008-11-03 | 2012-03-29 | シェーリング コーポレイション | 炎症性腸疾患生物マーカーおよび関連治療方法 |
| JO3244B1 (ar) | 2009-10-26 | 2018-03-08 | Amgen Inc | بروتينات ربط مستضادات il – 23 البشرية |
| EP2635601B1 (en) * | 2010-11-04 | 2016-07-20 | Boehringer Ingelheim International GmbH | Anti-il-23 antibodies |
| TWI636063B (zh) | 2013-03-08 | 2018-09-21 | 美國禮來大藥廠 | 結合ｉｌ－２３之抗體 |
| US20170002060A1 (en) * | 2014-01-08 | 2017-01-05 | Moderna Therapeutics, Inc. | Polynucleotides for the in vivo production of antibodies |
| US20190269757A1 (en) * | 2018-03-05 | 2019-09-05 | Janssen Biotech, Inc. | Methods of Treating Crohn's Disease with Anti-IL23 Specific Antibody |
-
2019
- 2019-03-27 TW TW108110767A patent/TWI744617B/zh active
- 2019-03-27 TW TW110139868A patent/TWI837532B/zh active
- 2019-03-28 MX MX2020010269A patent/MX2020010269A/es unknown
- 2019-03-28 EP EP19722256.5A patent/EP3773715B1/en active Active
- 2019-03-28 JP JP2020552872A patent/JP7119114B2/ja active Active
- 2019-03-28 KR KR1020207027982A patent/KR102552693B1/ko active Active
- 2019-03-28 MD MDE20210135T patent/MD3773715T2/ro unknown
- 2019-03-28 UA UAA202005571A patent/UA128578C2/uk unknown
- 2019-03-28 LT LTEPPCT/US2019/024633T patent/LT3773715T/lt unknown
- 2019-03-28 ES ES19722256T patent/ES2983809T3/es active Active
- 2019-03-28 EP EP23215626.5A patent/EP4327866B1/en active Active
- 2019-03-28 BR BR112020018099-8A patent/BR112020018099A2/pt unknown
- 2019-03-28 HU HUE19722256A patent/HUE067445T2/hu unknown
- 2019-03-28 RS RS20240698A patent/RS65661B1/sr unknown
- 2019-03-28 EA EA202091989A patent/EA202091989A1/ru unknown
- 2019-03-28 MA MA52216A patent/MA52216B1/fr unknown
- 2019-03-28 IL IL277514A patent/IL277514B2/en unknown
- 2019-03-28 PT PT197222565T patent/PT3773715T/pt unknown
- 2019-03-28 CA CA3095297A patent/CA3095297A1/en active Pending
- 2019-03-28 US US16/981,915 patent/US12152072B2/en active Active
- 2019-03-28 MY MYPI2020004942A patent/MY202368A/en unknown
- 2019-03-28 DK DK19722256.5T patent/DK3773715T3/da active
- 2019-03-28 CN CN201980023563.3A patent/CN111936165A/zh active Pending
- 2019-03-28 PL PL19722256.5T patent/PL3773715T3/pl unknown
- 2019-03-28 IL IL312807A patent/IL312807B2/en unknown
- 2019-03-28 FI FIEP19722256.5T patent/FI3773715T3/fi active
- 2019-03-28 SG SG11202009526RA patent/SG11202009526RA/en unknown
- 2019-03-28 HR HRP20240904TT patent/HRP20240904T1/hr unknown
- 2019-03-28 WO PCT/US2019/024633 patent/WO2019191464A1/en not_active Ceased
- 2019-03-28 AU AU2019243283A patent/AU2019243283C1/en active Active
- 2019-03-28 SI SI201930750T patent/SI3773715T1/sl unknown
-
2020
- 2020-08-28 ZA ZA2020/05388A patent/ZA202005388B/en unknown
-
2022
- 2022-08-03 JP JP2022123689A patent/JP7331219B2/ja active Active
-
2023
- 2023-08-09 JP JP2023130117A patent/JP7571225B2/ja active Active
- 2023-10-11 AU AU2023248103A patent/AU2023248103A1/en active Pending
-
2024
- 2024-10-09 JP JP2024176901A patent/JP2025020134A/ja active Pending
- 2024-10-16 US US18/917,597 patent/US20250034243A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUS2500039I1 (hu) | Elafibranor primer biliáris cirrózis kezelésében történõ alkalmazásra | |
| PL3773715T3 (pl) | Mirikizumab w leczeniu wrzodziejącego zapalenia jelita grubego | |
| MA45192A (fr) | Traitement d'association | |
| DK3562486T3 (da) | Anvendelse af sublingual dexmedetomidin til behandling af agitation | |
| PL3503890T3 (pl) | Stosowanie pridopidyny w leczeniu dystonii | |
| PL3265053T3 (pl) | Sposoby leczenia skóry | |
| PL3157512T3 (pl) | Zastosowanie kannabidioli w leczeniu padaczki | |
| IL258259B (en) | Adjunctive therapy with 25-hydroxyvitamin d and articles therefor | |
| EP3564335A4 (en) | SURFACE TREATMENT AGENT | |
| DK3481846T3 (da) | 11-substituerede 24-hydroxysteroler til anvendelse til behandling af nmda-relaterede tilstande | |
| EP3409744A4 (en) | SURFACE TREATMENT AGENT | |
| DK3710000T3 (da) | Tradipitant til anvendelse til behandling af gastroparese | |
| EP3858943A4 (en) | Surface treatment agent | |
| PL3493812T3 (pl) | Połączenia imetelstatu i wenetoklaksu do leczenia ostrej białaczki szpikowej | |
| DK3576738T3 (da) | Gaboxadolmonohydrat i behandling af tinnitus | |
| EP3431566A4 (en) | SURFACE TREATMENT AGENT | |
| EP3619170A4 (en) | WATER TREATMENT PROCESS | |
| PL3236960T3 (pl) | Fluralaner do zastosowania w leczeniu demodekozy | |
| PL3732294T3 (pl) | Tymohydrochinon do stosowania w leczeniu hiperglikemii | |
| DK3706739T3 (da) | Anvendelse af riluzolprodrugs til behandling af ataksier | |
| PT3331610T (pt) | Agentes para utilização no tratamento de glioma | |
| EP3493821A4 (en) | METHOD OF TREATING THE RESPIRATORY TRACT | |
| DK3243970T3 (da) | Bruseafløb og gulv | |
| HUE056798T2 (hu) | Imatinib stroke kezelésében való alkalmazásra | |
| PL3373922T3 (pl) | Kompozycje i sposoby do stosowania do leczenia homocystynurii |